Mammography Systems Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034

Growth Factors of mammography systems Market

The global mammography systems market size was valued at USD 2.49 billion in 2025 and is projected to grow from USD 2.69 billion in 2026 to USD 4.77 billion by 2034, exhibiting a CAGR of 7.4% during the forecast period. North America dominated the global market with a 44.58% market share in 2025, driven by strong breast cancer screening programs, widespread adoption of advanced imaging technologies, and favorable reimbursement policies.

Mammography systems are specialized medical imaging platforms used for the screening, diagnosis, and evaluation of breast abnormalities, particularly breast cancer. These systems include digital mammography, digital breast tomosynthesis (DBT), and contrast-enhanced mammography technologies. Increasing breast cancer incidence worldwide and growing adoption of AI-enabled imaging solutions are key factors supporting market growth.

Leading manufacturers such as GE HealthCare, Hologic, Inc., and Siemens Healthineers AG accounted for the largest market share in 2025 owing to their strong global presence, advanced product portfolios, and extensive installed base.

Mammography Systems Market Trends

Growing Adoption of 3D Mammography and AI-Powered Imaging

One of the most significant trends shaping the market is the transition from conventional 2D mammography to 3D mammography or digital breast tomosynthesis (DBT). Healthcare providers are increasingly adopting DBT because it improves lesion visibility and reduces tissue overlap, resulting in higher cancer detection rates.

In addition, AI-powered software solutions are being integrated into mammography workflows to support image interpretation, automate reporting, improve diagnostic confidence, and enhance radiologist productivity. These innovations are helping healthcare facilities improve screening accuracy while managing increasing patient volumes.

Market Drivers

Rising Breast Cancer Incidence Driving Demand

The increasing prevalence of breast cancer worldwide is a major factor fueling market expansion. According to the National Cancer Institute, approximately 316,950 new breast cancer cases were reported in 2025. Growing awareness regarding early diagnosis and screening is encouraging healthcare providers to invest in advanced mammography technologies.

The adoption of digital mammography and DBT systems is increasing as these technologies offer improved image quality, better detection rates, and enhanced performance in women with dense breast tissue. These benefits are expected to continue supporting mammography systems market growth throughout the forecast period.

Market Restraints

High Equipment and Operational Costs

Despite strong demand, the high acquisition and maintenance costs of mammography systems remain a significant challenge. Advanced digital and tomosynthesis systems require substantial capital investment, regular servicing, software upgrades, and compliance with quality-control regulations.

Smaller hospitals and diagnostic centers, particularly in developing regions, often delay equipment upgrades due to budget limitations. This factor is expected to restrain market growth during the forecast period.

Market Opportunities

AI Integration and Expansion in Emerging Markets

Artificial intelligence is creating substantial opportunities across the mammography ecosystem. AI-powered breast imaging solutions improve cancer detection efficiency, reduce reading times, and support radiologists in managing increasing workloads.

Additionally, healthcare infrastructure expansion in emerging economies is generating demand for modern breast imaging equipment. Increasing investments in women's healthcare and screening programs are expected to create new growth avenues for manufacturers over the coming years.

Market Challenges

Radiologist Shortages and Screening Accessibility Issues

A shortage of skilled radiologists and imaging professionals continues to challenge the market. Several countries face difficulties in maintaining adequate screening coverage due to workforce limitations and uneven healthcare infrastructure.

Furthermore, integrating AI systems, PACS platforms, reporting software, and advanced biopsy workflows increases operational complexity for healthcare providers. These challenges may slow adoption in some regions.

Segmentation Analysis

By Type

The digital segment accounted for the largest share of the global mammography systems market in 2025. The growth of this segment is attributed to increasing adoption of digital imaging technologies, superior diagnostic accuracy, and continuous product innovations by major manufacturers.

The analog segment is projected to grow at a CAGR of 3.8% during the forecast period, supported primarily by demand from cost-sensitive healthcare facilities.

By End User

The hospitals segment dominated the market in 2025 due to high patient volumes, availability of advanced diagnostic infrastructure, and increasing breast cancer screening programs. The segment is expected to account for 45.8% of the market in 2026.

Meanwhile, the diagnostic imaging centers segment is projected to register the fastest growth, expanding at a CAGR of 8.3% through 2034.

Regional Analysis

North America

North America remained the largest regional market, reaching USD 1.11 billion in 2025. The region benefits from strong awareness programs, extensive adoption of digital mammography and DBT systems, and rapid implementation of AI-based breast imaging technologies.

The U.S. mammography systems market is projected to reach USD 1.15 billion in 2026, representing approximately 42.8% of global market revenue.

Europe

Europe is expected to grow at a 6.1% CAGR and reach USD 0.57 billion in 2026. The region benefits from well-established screening programs, a large network of imaging centers, and increasing investments in advanced diagnostic technologies.

Germany is projected to reach USD 0.14 billion in 2026, while the U.K. market is expected to reach USD 0.07 billion.

Asia Pacific

Asia Pacific is anticipated to become the second-largest regional market, reaching approximately USD 0.53 billion in 2026. Rising breast cancer awareness, growing healthcare expenditure, and improving diagnostic infrastructure are supporting regional growth.

China is expected to generate USD 0.26 billion in revenue by 2026, while Japan and India are projected to reach USD 0.10 billion and USD 0.03 billion, respectively.

Latin America and Middle East & Africa

These regions are expected to witness steady growth due to increasing screening awareness, expanding healthcare infrastructure, and government initiatives focused on early cancer detection.

Latin America is projected to reach USD 0.24 billion in 2026, while the GCC market is expected to attain approximately USD 0.06 billion.

Competitive Landscape

The mammography systems market is highly competitive, with leading companies focusing on technological innovation, AI integration, and product portfolio expansion. Major players operating in the market include Hologic, Inc., GE HealthCare, Siemens Healthineers AG, Fujifilm Holdings Corporation, Planmed Oy, Metaltronica S.p.A., Trivitron Healthcare, Shanghai United Imaging Healthcare Co., LTD, Genoray, and SternMed GmbH.

These companies continue to invest in next-generation digital mammography systems, AI-assisted detection platforms, and strategic expansion initiatives to strengthen their global market position.

Key Industry Developments

• January 2026: Vega Imaging Informatics curated the world's largest digital breast tomosynthesis dataset containing over one million studies.
• October 2025: RAYUS Radiology launched Transpara Breast AI services across clinics in Washington State.
• June 2025: Dharamshila Narayana Superspeciality Hospital introduced an advanced 3D mammography system in Delhi.
• January 2025: Siemens Healthineers installed the first Mammomat B.brilliant mammography system in the U.S.
• December 2024: GE HealthCare launched the Pristina Via mammography platform.
• October 2024: Siemens Healthineers received FDA approval for the 3D tomosynthesis component of Mammomat B.brilliant.
• February 2024: Fujifilm introduced the AMULET SOPHINITY digital mammography technology at ECR 2024.

Conclusion

The global mammography systems market is positioned for strong growth, increasing from USD 2.49 billion in 2025 to USD 2.69 billion in 2026, and reaching USD 4.77 billion by 2034. Rising breast cancer incidence, expanding adoption of 3D mammography, growing integration of AI-enabled diagnostic tools, and increasing investments in women's healthcare are expected to drive market expansion. While high equipment costs and shortages of skilled radiologists remain challenges, technological advancements and growing screening initiatives across emerging markets will continue to create substantial opportunities for industry participants throughout the forecast period.

Segmentation By Type, End-user, and Region

By Type * Digital

• Analog

By End-user * Hospitals

• Specialty Clinics
• Diagnostic Imaging Centers
• Others

By Region * North America (By Type, End-user, and Country)

• U.S. (By Type)
• Canada (By Type)
• Europe (By Type, End-user, and Country/Sub-region)
  • Germany (By Type)
  • U.K. (By Type)
  • France (By Type)
  • Spain (By Type)
  • Italy (By Type)
  • Scandinavia (By Type)
  • Rest of Europe (By Type)
• Asia Pacific (By Type, End-user, and Country/Sub-region)
  • China (By Type)
  • Japan (By Type)
  • India (By Type)
  • Australia (By Type)
  • Southeast Asia (By Type)
  • Rest of Asia Pacific (By Type)
• Latin America ( By Type, End-user, and Country/Sub-region)
  • Brazil (By Type)
  • Mexico (By Type)
  • Rest of Latin America (By Type)
• Middle East & Africa (By Type, End-user, and Country/Sub-region)
  • GCC (By Type)
  • South Africa (By Type)
  • Rest of the Middle East & Africa (By Type)